Citation: Manoj Kumar Rajput. Mutations and methods of analysis of mutations in Hepatitis B virus[J]. AIMS Microbiology, 2020, 6(4): 401-421. doi: 10.3934/microbiol.2020024
[1] |
Dienstag JL (2008) Hepatitis B virus infection. N Engl J Med 359: 1486-500. doi: 10.1056/NEJMra0801644
![]() |
[2] |
Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64: 51-68. doi: 10.1128/MMBR.64.1.51-68.2000
![]() |
[3] |
Orito E, Mizokami M, Ina Y (1989) Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci USA 86: 7059-7062. doi: 10.1073/pnas.86.18.7059
![]() |
[4] |
Gunther S, Sommer G, Plikat U, et al. (1997) Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G-->A hypermutation. Virology 235: 104-108. doi: 10.1006/viro.1997.8676
![]() |
[5] |
Henningfeld KA, Hecht SM (1995) A model for topoisomerase I-mediated insertions and deletions with duplex DNA substrates containing branches, nicks, and gaps. Biochemistry 34: 6120-6129. doi: 10.1021/bi00018a015
![]() |
[6] |
Liao H, Li X, Liu Y, et al. (2017) Intergenotype recombinant analysis of full-length hepatitis B virus genomes from 516 Chinese patients with different illness categories. J Med Virol 89: 139-145. doi: 10.1002/jmv.24609
![]() |
[7] |
Chavan YG, Pawar SR, Wani M, et al. (2017) Hepatitis B virus DNA polymerase gene polymorphism based prediction of genotypes in chronic HBV patients from Western India. Afr Health Sci 17: 762-772. doi: 10.4314/ahs.v17i3.19
![]() |
[8] |
Wang X, Xu L, Chen Y, et al. (2017) Integrating nested PCR with high-throughput sequencing to characterize mutations of HBV genome in low viral load samples. Medicine (Baltimore) 96: e7588. doi: 10.1097/MD.0000000000007588
![]() |
[9] |
Lindh M, Andersson AS, Gusdal A (1997) Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method. J Infect Dis 175: 1285-1293. doi: 10.1086/516458
![]() |
[10] |
Wang YZ, Zhu Z, Zhang HY, et al. (2014) Detection of hepatitis B virus A1762T/G1764A mutant by amplification refractory mutations ystem. Braz J Infect Dis 18: 261-265. doi: 10.1016/j.bjid.2013.09.005
![]() |
[11] |
Hua R, Tanaka Y, Fukai K, et al. (2008) Rapid detection of the hepatitis B virus YMDD mutant using TaqMan-minor groove binder probes. Clin Chim Acta 395: 151-154. doi: 10.1016/j.cca.2008.06.013
![]() |
[12] |
Hardie DR, Kannemeyer J, Stannard LM (1996) DNA single strand conformation polymorphism identifies five defined strains of hepatitis B virus (HBV) during an outbreak of HBV infection in an oncology unit. J Med Virol 49: 49-54. doi: 10.1002/(SICI)1096-9071(199605)49:1<49::AID-JMV8>3.0.CO;2-K
![]() |
[13] |
Gunther S, Li BC, Miska S, et al. (1995) A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol 69: 5437-5444. doi: 10.1128/JVI.69.9.5437-5444.1995
![]() |
[14] |
Xiao T, Zhou W (2020) The third generation sequencing: the advanced approach to genetic diseases. Translational pediatrics 9: 163-173. doi: 10.21037/tp.2020.03.06
![]() |
[15] |
Kramvis A, Kew MC (1998) Structure and function of the encapsidationsignal of hepadnaviridae. J Viral Hepat 5: 357-367. doi: 10.1046/j.1365-2893.1998.00124.x
![]() |
[16] |
Jammeh S, Tavner F, Watson R, et al. (2008) Effect of basal core promoter and pre-core mutations on hepatitis B virus replication. J Gen Virol 89: 901-909. doi: 10.1099/vir.0.83468-0
![]() |
[17] |
Buckwold VE, Xu Z, Yen TS, et al. (1997) Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 78: 2055-2065. doi: 10.1099/0022-1317-78-8-2055
![]() |
[18] |
Gunther S, Paulij W, Meisel H, et al. (1998) Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity. Virology 244: 146-160. doi: 10.1006/viro.1998.9079
![]() |
[19] |
Gunther S, Piwon N, Iwanska A, et al. (1996) Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J Virol 70: 8318-8331. doi: 10.1128/JVI.70.12.8318-8331.1996
![]() |
[20] |
Preisler-Adams S, Schlayer HJ, Peters T, et al. (1993) Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol 133: 385-396. doi: 10.1007/BF01313777
![]() |
[21] |
Kim JH, Kang S, Kim J, et al. (2003) Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein. J Virol 77: 7166-7173. doi: 10.1128/JVI.77.13.7166-7173.2003
![]() |
[22] |
Uchida T, Gotoh K, Shikata T (1995) Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B. J Med Virol 45: 247-252. doi: 10.1002/jmv.1890450303
![]() |
[23] |
Feitelson MA, Duan LX, Guo J, et al. (1995) Precore and X region mutants in hepatitis B virus infections among renal dialysis patients. J Viral Hepat 2: 19-31. doi: 10.1111/j.1365-2893.1995.tb00068.x
![]() |
[24] |
Inoue J, Ueno Y, Wakui Y, et al. (2011) Enhanced replication of hepatitis B virus with frame shift in the precoreregion found in fulminant hepatitis patients. J Infect Dis 204: 1017-1025. doi: 10.1093/infdis/jir485
![]() |
[25] |
Hai H, Tamori A, Kawada N (2014) Role of hepatitis B virus DNA integration in human hepatocarcinogenesis. World J Gastroenterol 20: 6236-6243. doi: 10.3748/wjg.v20.i20.6236
![]() |
[26] |
Bouchard MJ, Schneider RJ (2004) The enigmatic X gene of hepatitis B virus. J Virol 78: 12725-12734. doi: 10.1128/JVI.78.23.12725-12734.2004
![]() |
[27] |
Kramvis A, Kostaki EG, Hatzakis A, et al. (2018) Immunomodulatory function of HBeAg related to short-sighted evolution, transmissibility, and clinical manifestation of Hepatitis B virus. Front Microbiol 9: 2521. doi: 10.3389/fmicb.2018.02521
![]() |
[28] | Milich DR, McLachlan A, Moriarty A, et al. (1987) Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. J Immunol 139: 1223-1231. |
[29] |
Quarleri J (2014) Core promoter: A critical region where the hepatitis B virus makes decisions. World J Gastroenterol 20: 425-435. doi: 10.3748/wjg.v20.i2.425
![]() |
[30] |
Lin CL, Liao LY, Liu CJ, et al. (2002) Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. J Gastroenterol 37: 283-287. doi: 10.1007/s005350200036
![]() |
[31] |
Laskus T, Rakela J, Persing DH (1994) The stem-loop structure of the cis-encapsidation signal is highly conserved in naturally occurring hepatitis B virus variants. Virology 200: 809-812. doi: 10.1006/viro.1994.1247
![]() |
[32] |
Tong SP, Li JS, Vitvitski L, et al. (1992) Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal. Virology 191: 237-245. doi: 10.1016/0042-6822(92)90185-R
![]() |
[33] |
Tong SP, Li JS, Vitvitski L, et al. (1993) Evidence for a base-paired region of hepatitis B virus pregenome encapsidation signal which influences the patterns of precore mutations abolishing HBe protein expression. J Virol 67: 5651-5655. doi: 10.1128/JVI.67.9.5651-5655.1993
![]() |
[34] | Guo Y, Hou J, Luo K, et al. (2001) Genetic mutations of precoreregion of hepatitis B virus in hepatitis B e antigen-negative patients with fulminant hepatitis B and translation of precore variants in vitro. Zhonghua Gan Zang Bing Za Zhi 9: 42-44. |
[35] |
Gunther S, Meisel H, Reip A, et al. (1992) Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology 187: 271-279. doi: 10.1016/0042-6822(92)90315-G
![]() |
[36] |
Ingman M, Lindqvist B, Kidd-Ljunggren K (2006) Novel mutation in Hepatitis B virus preventing HBeAg production and resembling primate strains. J Gen Virol 87: 307-310. doi: 10.1099/vir.0.81562-0
![]() |
[37] |
Laskus T, Rakela J, Persing DH (1995) Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon. Dig Dis Sci 40: 1-7. doi: 10.1007/BF02063933
![]() |
[38] |
Marinos G, Torre F, Gunther S, et al. (1996) Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. Gastroenterology 111: 183-192. doi: 10.1053/gast.1996.v111.pm8698197
![]() |
[39] |
Santantonio T, Jung MC, Schneider R, et al. (1991) Selection for a pre-C stop codon mutation in a hepatitis B virus variant with a pre-C initiation codon mutation during interferon treatment. J Hepatol 13: 368-371. doi: 10.1016/0168-8278(91)90083-N
![]() |
[40] |
Grandjacques C, Pradat P, Stuyver L, et al. (2000) Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity. J Hepatol 33: 430-439. doi: 10.1016/S0168-8278(00)80279-2
![]() |
[41] |
Nakahori S, Yokosuka O, Ehata T, et al. (1995) Detection of hepatitis B virus precore stop codon mutants by selective amplification method: frequent detection of precore mutants in hepatitis B e antigen positive healthy carriers. J Gastroenterol Hepatol 10: 419-425. doi: 10.1111/j.1440-1746.1995.tb01594.x
![]() |
[42] |
Zhong S, Chan JY, Yeo W, et al. (2000) Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues. J Viral Hepat 7: 115-123. doi: 10.1046/j.1365-2893.2000.00209.x
![]() |
[43] |
Naumann U, Protzer-Knolle U, Berg T, et al. (1997) A pretransplant infection with precore mutants of hepatitis B virus does not influence the outcome of orthotopic liver transplantation in patients on high dose anti-hepatitis B virus surface antigen immunoprophylaxis. Hepatology 26: 478-484. doi: 10.1002/hep.510260232
![]() |
[44] |
Salfeld J, Pfaff E, Noah M, et al. (1989) Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol 63: 798-808. doi: 10.1128/JVI.63.2.798-808.1989
![]() |
[45] |
Sallberg M, Ruden U, Wahren B, et al. (2012) Human and murine B-cells recognize the HBeAg/beta (or HBe2) epitope as a linear determinant. Mol Immunol 28: 719-726. doi: 10.1016/0161-5890(91)90114-Y
![]() |
[46] |
Konig S, Beterams G, Nassal M (1998) Mapping of homologous interaction sites in the hepatitis B virus core protein. J Virol 72: 4997-5005. doi: 10.1128/JVI.72.6.4997-5005.1998
![]() |
[47] |
Metzger K, Bringas R (1998) Proline-138 is essential for the assembly of hepatitis B virus core protein. J Gen Virol 79: 587-590. doi: 10.1099/0022-1317-79-3-587
![]() |
[48] |
Zlotnick A, Cheng N, Stahl SJ, et al. (1997) Localization of the C-terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA. Proc Natl Acad Sci USA 94: 9556-9561. doi: 10.1073/pnas.94.18.9556
![]() |
[49] |
Ehata T, Omata M, Chuang WL, et al. (1993) Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 91: 1206-1213. doi: 10.1172/JCI116281
![]() |
[50] |
Bertoletti A, Costanzo A, Chisari FV, et al. (1994) Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180: 933-943. doi: 10.1084/jem.180.3.933
![]() |
[51] |
Rehermann B, Fowler P, Sidney J, et al. (1995) The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 181: 1047-1058. doi: 10.1084/jem.181.3.1047
![]() |
[52] |
Hosono S, Tai PC, Wang W, et al. (1995) Core antigen mutations of human hepatitis B virus in hepatomas accumulate in MHC class II-restricted T cell epitopes. Virology 212: 151-162. doi: 10.1006/viro.1995.1463
![]() |
[53] |
Minami M, Poussin K, Kew M, et al. (1996) Precore/core mutations of hepatitis B virus in hepatocellular carcinomas developed on non-cirrhotic livers. Gastroenterology 111: 691-700. doi: 10.1053/gast.1996.v111.pm8780574
![]() |
[54] |
Yuan TT, Sahu GK, Whitehead WE, et al. (1999) The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol 73: 5731-5740. doi: 10.1128/JVI.73.7.5731-5740.1999
![]() |
[55] |
Schories M, Peters T, Rasenack J (2000) Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 33: 799-811. doi: 10.1016/S0168-8278(00)80313-X
![]() |
[56] |
Alexopoulou A, Karayiannis P, Hadziyannis SJ, et al. (1997) Emergence and selection of HBV variants in an anti-HBe positive patient persistently infected with quasi-species. J Hepatol 26: 748-753. doi: 10.1016/S0168-8278(97)80238-3
![]() |
[57] |
Kreutz C (2002) Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 6: 113-143. doi: 10.1111/j.1582-4934.2002.tb00317.x
![]() |
[58] |
Okamoto H, Wang Y, Tanaka T, et al. (1993) Machida A, Miyakawa Y, Mayumi M. Trans-complementation among naturally occurring deletion mutants of hepatitis B virus and integrated viral DNA for the production of viral particles with mutant genomes in hepatoma cell lines. J Gen Virol 74: 407-414. doi: 10.1099/0022-1317-74-3-407
![]() |
[59] |
Peiffer KH, Akhras S, Himmelsbach K, et al. (2015) Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI level. J Hepatol 62: 791-798. doi: 10.1016/j.jhep.2014.11.028
![]() |
[60] |
Delfini C, Colloca S, Taliani G, et al. (1989) Clearance of hepatitis B virus DNA and pre-S surface antigens in patients with markers of acute viral replication. J Med Virol 28: 169-175. doi: 10.1002/jmv.1890280312
![]() |
[61] |
Melegari M, Scaglioni PP, Wands JR (1997) The small envelope protein is required for secretion of a naturally occurring hepatitis B virus mutant with pre-S1 deleted. J Virol 71: 5449-5454. doi: 10.1128/JVI.71.7.5449-5454.1997
![]() |
[62] |
Chua PK, Wang RY, Lin MH, et al. (2005) Reduced secretion of virions and hepatitis B virus (HBV) surface antigen of a naturally occurring HBV variant correlates with the accumulation of the small S envelope protein in the endoplasmic reticulum and Golgi apparatus. J Virol 79: 13483-13496. doi: 10.1128/JVI.79.21.13483-13496.2005
![]() |
[63] |
Gao ZY, Li T, Wang J, et al. (2007) Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma. J Gastroenterol 42: 761-768. doi: 10.1007/s00535-007-2085-1
![]() |
[64] |
Yamamoto K, Horikita M, Tsuda F, et al. (1994) Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 68: 2671-2676. doi: 10.1128/JVI.68.4.2671-2676.1994
![]() |
[65] |
Li D, He W, Liu X (2017) A potent human neutralizing antibody Fc-dependently reduces established HBV infections. Elife 6: e26738. doi: 10.7554/eLife.26738
![]() |
[66] |
Fernholz D, Galle PR, Stemler M, et al. (1993) Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. Virology 194: 137-148. doi: 10.1006/viro.1993.1243
![]() |
[67] |
Raney AK, McLachlan A (1997) Characterization of the hepatitis B virus major surface antigen promoter hepatocyte nuclear factor 3 binding site. J Gen Virol 78: 3029-3038. doi: 10.1099/0022-1317-78-11-3029
![]() |
[68] |
Horikita M, Itoh S, Yamamoto K, et al. (1994) Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. J Med Virol 44: 96-103. doi: 10.1002/jmv.1890440118
![]() |
[69] |
Gerner PR, Friedt M, Oettinger R, et al. (1998) The hepatitis B virus seroconversion to anti-HBe is frequently associated with HBV genotype changes and selection of preS2-defective particles in chronically infected children. Virology 245: 163-172. doi: 10.1006/viro.1998.9126
![]() |
[70] |
Lu CC, Yen TS (1996) Activation of the hepatitis B virus S promoter by transcription factor NF-Y via a CCAAT element. Virology 225: 387-394. doi: 10.1006/viro.1996.0613
![]() |
[71] |
Chen BF, Liu CJ, Jow GM, et al. (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-1168. doi: 10.1053/j.gastro.2006.01.011
![]() |
[72] |
Hildt E, Saher G, Bruss V, et al. (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225: 235-239. doi: 10.1006/viro.1996.0594
![]() |
[73] |
Bruss V (1997) A short linear sequence in the pre-S domain of the large hepatitis B virus envelope protein required for virion formation. J Virol 71: 9350-9357. doi: 10.1128/JVI.71.12.9350-9357.1997
![]() |
[74] |
Lenhoff RJ, Summers J (1994) Coordinate regulation of replication and virus assembly by the large envelope protein of an avian hepadnavirus. J Virol 68: 4565-4571. doi: 10.1128/JVI.68.7.4565-4571.1994
![]() |
[75] |
Nakajima E, Minami M, Ochiya T, et al. (1994) PreS1 deleted variants of hepatitis B virus in patients with chronic hepatitis. J Hepatol 20: 329-335. doi: 10.1016/S0168-8278(94)80003-0
![]() |
[76] |
Santantonio T, Jung MC, Schneider R, et al. (1992) Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology 188: 948-952. doi: 10.1016/0042-6822(92)90559-8
![]() |
[77] |
Hur GM, Lee YI, Suh DJ, et al. (1996) Gradual accumulation of mutations in precore core region of HBV in patients with chronic active hepatitis: implications of clustering changes in a small region of the HBV core region. J Med Virol 48: 38-46. doi: 10.1002/(SICI)1096-9071(199601)48:1<38::AID-JMV6>3.0.CO;2-M
![]() |
[78] |
Kohno H, Inoue T, Tsuda F, et al. (1996) Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B. J Gen Virol 77: 1825-1831. doi: 10.1099/0022-1317-77-8-1825
![]() |
[79] |
Riedl P, El-Kholy S, Reimann J, et al. (2002) Priming biologically active antibody responses against an isolated, conformational viral epitope by DNA vaccination. J Immunol 169: 1251-1260. doi: 10.4049/jimmunol.169.3.1251
![]() |
[80] |
Salpini R, Colagrossi L, Bellocchi MC (2015) Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology 61: 823-833. doi: 10.1002/hep.27604
![]() |
[81] |
Rodriguez-Frias F, Buti M, Jardi R, et al. (1999) Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation. Liver 19: 177-182. doi: 10.1111/j.1478-3231.1999.tb00032.x
![]() |
[82] |
Ogata N, Zanetti AR, Yu M, et al. (1997) Infectivity and pathogenicity in chimpanzees of a surface gene mutant of hepatitis B virus that emerged in a vaccinated infant. J Infect Dis 175: 511-523. doi: 10.1093/infdis/175.3.511
![]() |
[83] |
Ngui SL, Andrews NJ, Underhill GS, et al. (1998) Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 27: 100-106. doi: 10.1086/514610
![]() |
[84] |
Lee YI, Hong YB, Kim Y, et al. (1997) RNaseH activity of human hepatitis B virus polymerase expressed in Escherichia coli. Biochem Biophys Res Commun 233: 401-407. doi: 10.1006/bbrc.1997.6467
![]() |
[85] |
Ghany MG, Ayola B, Villamil FG, et al. (1998) Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 27: 213-222. doi: 10.1002/hep.510270133
![]() |
[86] |
Carman WF, Trautwein C, van Deursen FJ, et al. (1996) Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 24: 489-493. doi: 10.1002/hep.510240304
![]() |
[87] |
Tai PC, Banik D, Lin GI, et al. (1997) Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J Virol 71: 4852-4856. doi: 10.1128/JVI.71.6.4852-4856.1997
![]() |
[88] |
Zeinab Nabil Ahmed Said (2011) An overview of occult hepatitis B virus infection. World J Gastroenterol 17: 1927-1938. doi: 10.3748/wjg.v17.i15.1927
![]() |
[89] |
Carman WF (1997) The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4: 11-20. doi: 10.1111/j.1365-2893.1997.tb00155.x
![]() |
[90] |
Zhang YY, Nordenfelt E, Hansson BG (1996) Increasing heterogeneity of the ‘a’ determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection. Scand J Infect Dis 28: 9-15. doi: 10.3109/00365549609027142
![]() |
[91] |
Grethe S, Monazahian M, Bohme I, et al. (1998) Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 72: 7692-7696. doi: 10.1128/JVI.72.9.7692-7696.1998
![]() |
[92] |
Cooreman MP, Leroux-Roels G, Paulij WP (2001) Vaccine and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8: 237-247. doi: 10.1007/BF02256597
![]() |
[93] |
Protzer-Knolle U, Naumann U, Bartenschlager R, et al. (1998) Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27: 254-263. doi: 10.1002/hep.510270138
![]() |
[94] |
Chen Y, Qian F, Yuan Q, et al. (2011) Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs. J Clin Virol 52: 198-203. doi: 10.1016/j.jcv.2011.07.011
![]() |
[95] |
Allen MI, Deslauriers M, Andrews CW, et al. (1998) Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology 27: 1670-1677. doi: 10.1002/hep.510270628
![]() |
[96] |
Ono-Nita SK, Kato N, Shiratori Y, et al. (1999) Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors. J Clin Investig 103: 1635-1640. doi: 10.1172/JCI5882
![]() |
[97] |
Melegari M, Scaglioni PP, Wands JR (1998) Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective. Hepatology 27: 628-633. doi: 10.1002/hep.510270243
![]() |
[98] | Ladner SK, Miller TJ, Otto MJ, et al. (1998) The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues. Antivir Chem Chemother 9: 65-72. |
[99] |
Stuyver LJ, Lostia S, Adams M, et al. (2002) Antiviral activities and cellular toxicities of modified 2′,3′-dideoxy-2′,3′-didehydrocytidine analogues. Antimicrob Agents Chemother 46: 3854-3860. doi: 10.1128/AAC.46.12.3854-3860.2002
![]() |
[100] |
Bartholomeusz A, Locarnini SA (2006) Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis 26: 162-170. doi: 10.1055/s-2006-939758
![]() |
[101] |
Oon CJ, Chen WN, Lim N, et al. (1999) Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the ‘a’ epitope of the surface antigen are sensitive to ganciclovir. Antiviral Res 41: 113-118. doi: 10.1016/S0166-3542(99)00007-8
![]() |
[102] |
de Man RA, Bartholomeusz AI, Niesters HG, et al. (1998) The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss. J Hepatol 29: 669-675. doi: 10.1016/S0168-8278(98)80164-5
![]() |
[103] | Pillay D (1998) Emergence and control of resistance to antiviral drugs in resistance in herpes viruses, hepatitis B virus, and HIV. Commun Dis Public Health 1: 5-13. |
[104] |
Chin R, Shaw T, Torresi J, et al. (2001) In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurinedioxolane and 2′-fluoro-5-methyl-beta-L-arabinofuranosyluracil. Antimicrob Agents Chemother 45: 2495-2501. doi: 10.1128/AAC.45.9.2495-2501.2001
![]() |
[105] |
Honkoop P, Niesters HG, de Man RA, et al. (1997) Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J Hepatol 26: 1393-1395. doi: 10.1016/S0168-8278(97)80476-X
![]() |
[106] |
Whalley SA, Brown D, Webster GJ, et al. (2004) Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology 127: 1131-1138. doi: 10.1053/j.gastro.2004.07.004
![]() |
[107] |
Mutimer D, Pillay D, Cook P, et al. (2000) Selection of multi resistant hepatitis B virus during sequential nucleoside-analogue therapy. J Infect Dis 181: 713-716. doi: 10.1086/315238
![]() |
[108] |
Kreutz C (2002) Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 6: 113-143. doi: 10.1111/j.1582-4934.2002.tb00317.x
![]() |
[109] |
Tu T, Budzinska MA, Shackel NA, et al. (2017) HBV DNA integration: molecular mechanisms and clinical implications. Viruses 9: 75. doi: 10.3390/v9040075
![]() |
[110] |
Sommer G, Gunther S, Sterneck M, et al. (1997) A new class of defective hepatitis B virus genomes with an internalpoly(dA) sequence. Virology 239: 402-412. doi: 10.1006/viro.1997.8898
![]() |
[111] |
Chen PJ, Chen CR, Sung JL, et al. (1989) Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus. J Virol 63: 4165-4171. doi: 10.1128/JVI.63.10.4165-4171.1989
![]() |
[112] |
Soussan P, Tuveri R, Nalpas B, et al. (2003) The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepato 38: 343-348. doi: 10.1016/S0168-8278(02)00422-1
![]() |
[113] |
Le Pogam S, Chua PK, Newman M, et al. (2005) Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg165–173). J Virol 79: 1871-1887. doi: 10.1128/JVI.79.3.1871-1887.2005
![]() |
[114] |
Bartenschlager R, Junker-Niepmann M, Schaller H (1990) The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 64: 5324-5332. doi: 10.1128/JVI.64.11.5324-5332.1990
![]() |
[115] |
Marschenz S, Brinckmann A, Nürnberg P, et al. (2008) Co-replication analyses of naturally occurring defective hepatitis B virus variants with wild-type. Virology 372: 247-259. doi: 10.1016/j.virol.2007.10.039
![]() |